Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Infusions, Intravenous × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 3 1 Phase 1 1

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Cyclophosphamide 260 Cisplatin 248 Radiotherapy 224 Paclitaxel 217 Fluorouracil 197 Docetaxel 197 Carboplatin 194 Doxorubicin 192 Dexamethasone 148 Gemcitabine 134 Vincristine 126 Capecitabine 116 Prednisone 113 Etoposide 112 Leucovorin 111 Methotrexate 104 Bevacizumab 104 Rituximab 98 Cytarabine 96 Filgrastim 85 Trastuzumab 81 Oxaliplatin 78 pembrolizumab 68 Pemetrexed 61 Drug Therapy 61 Tamoxifen 60 Epirubicin 58 Irinotecan 54 Granulocyte Colony-Stimulating Factor 52 Chemotherapy, Adjuvant 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00399035 2016-12-28

HORIZON II

AstraZeneca

Phase 3 Completed

1,254 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡